FDA updates its list with 56 new AI-powered radiology devices, bringing the total to over 1,000 approved tools.
Key Details
- 1FDA list updated in early December to include over 1,300 AI-enabled medical devices.
- 2Radiology remains the dominant application, with 1,039 out of total devices approved.
- 356 new radiology-specific AI devices added between mid-July and September.
- 4Nearly 80% of all FDA-cleared AI medical tools are for radiology.
- 5Major companies such as GE HealthCare, Siemens, Fujifilm, Qure.ai, and DeepHealth featured among the approvals.
- 6The number of approvals has surged from 500 at the start of 2023 to over 1,300 by year's end.
Why It Matters
This rapid expansion in FDA-approved AI devices underscores radiology’s central role in clinical imaging innovation and regulatory acceptance. Widespread adoption can further transform workflows, diagnostics, and care standards across medical imaging.
Source
Radiology Business
Related News
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.
•Radiology Business
FDA Clears AIRS Medical AI for Rapid MRI Body Composition Analysis
AIRS Medical's SwiftSight Body Composition AI software receives FDA 510(k) clearance for automated MRI-based body composition reporting.
•Radiology Business
GE HealthCare Appoints Chief AI Officer to Lead Imaging Innovation
GE HealthCare has hired Rodolphe Katra as its new global chief AI officer to drive its AI strategy in imaging.